Active ingredientVelpatasvirCat. No. P-V025-001CAS 1377049-84-7Family · Pharmaceutical analytical standards
Velpatasvir
An antiviral that blocks the NS5A protein of the hepatitis C virus, approved in 2016 in the United States and Europe in combination with sofosbuvir, in a single tablet. This family brings together the active ingredient and other impurities.
Did you know?Its combination with sofosbuvir was the first approved by the FDA to work against all six major genotypes of the virus: this is why it is called pangenotypic.
Go to the active ingredient →Active ingredientVelpatasvirCat. No. P-V025-001CAS 1377049-84-7
ImpurityDesi Alkyl VelpatasvirCat. No. P-V025-003
ImpurityDesi methoxycarbonyl VelpatasvirCat. No. P-V025-004
ImpurityVelpatasvir Impurity 1Cat. No. P-V025-005
ImpurityVelpatasvir Impurity 2Cat. No. P-V025-006
ImpurityVelpatasvir S-Phenyl DiastereomerCat. No. P-V025-007CAS 1493768-22-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.